Daniel Alexander King, MD, PhD (Oncology Fellow)
Originally from Long Island, NY, Dan trained at Cold Spring Harbor Laboratory, the University of Michigan (BS), Wayne State University (MD), the National Human Genome Research Institute (HHMI Research Scholars Program), Cambridge University (PhD), and Columbia University (Internal Medicine Residency). He enjoys mutation hunting in large-scale genomic data. He was most recently involved in an exome sequencing study of 12,000 children with rare disease and their parents, in which he developed new computational tools to identify large genetic aberrations. His mutational spectrum of interest includes uniparental disomy, copy number alterations, and mosaicism. He plans to explore research opportunities riding the intersection of new technology & genomics, such as single cell DNA & RNA sequencing, and circulating tumor DNA.
During oncology fellowship he has developed a passion for pancreatic cancer and specializes in caring for patients with pancreatic cancer in clinic with renowned medical oncologist Dr George Fisher. During fellowship his pancreatic research interests span the spectrum of translational research in pancreatic cancer. Several recent accomplishments include: 1) the development of a pancreatic cancer-specific circulating tumor DNA assay, the development of a pancreatic cancer research database containing thousands of patients who presented to Stanford with pancreatic cancer over the last twenty years, and the development of a large +500 sample biobank consisting of blood samples from generous pancreatic cancer patient study participants.